The Effect of Lactation Cookies on Breastfeeding Outcomes in Lactating Women
Launched by NOTRE DAME UNIVERSITY - LOUAIZE · Jun 17, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether eating special lactation cookies can help breastfeeding women produce more milk and make breastfeeding easier or more enjoyable. Researchers will compare these lactation cookies to regular cookies to see if they really make a difference in milk supply and the overall breastfeeding experience.
Women who might join the study need to be between 18 and 45 years old, have a healthy baby born at full term (at least 37 weeks), and be exclusively breastfeeding a baby who is at least one month old. Participants should live in Lebanon and plan to continue exclusive breastfeeding for at least two months. During the study, women will eat two cookies a day for 30 days, visit the clinic twice (once at the beginning and once at the end), and keep a simple daily record of their breastfeeding and cookie eating. The study does not include women with certain health conditions, allergies to the cookies, or those who smoke or drink alcohol. This study is not yet open for participants but aims to provide helpful information for breastfeeding mothers in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women 1 month postpartum
- • Exclusively breastfeeding
- • Aged 18-45 years
- • Healthy term infants (≥37 weeks gestation)
- • Uncomplicated pregnancies and births
- • Residing in Lebanon
- • Planning to exclusively breastfeed for at least 2 months
- • Intending to attend recommended pediatrician visits
- • Infants must be at least 1 month old
- Exclusion Criteria:
- • Twin pregnancy
- • Allergies or dislike of ingredients in the study cookies
- • Presence of any health condition including: thyroid disease, epilepsy, psychosis, or bipolar disorder
- • Currently receiving treatment for depression or anxiety
- • Mastitis
- • Smoking or alcohol consumption
- • Taking medications or substances that may affect milk production, including: metoclopramide, chlorpromazine, domperidone, herbal galactagogues, thyroid hormones, or blood thinning medications
About Notre Dame University Louaize
Notre Dame University – Louaize is a reputable academic institution committed to advancing research and innovation across diverse fields, including health sciences. As a clinical trial sponsor, the university emphasizes rigorous scientific standards and ethical practices to contribute meaningful insights that enhance patient care and public health outcomes. Through collaborative efforts and a strong academic foundation, Notre Dame University – Louaize supports studies aimed at improving medical knowledge and fostering evidence-based healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jounieh, , Lebanon
Patients applied
Trial Officials
Jessy El Hayek, PhD
Principal Investigator
Notre Dame University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported